Showing results (311-320 of 348) with videos related to

Sort By:
Pageof 35
Alimentary Pharmacology & Therapeutics|September 22, 2025
Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary CholangitisNadir Abbas, Rachel Smith, Ellina Lytvyak, et al.
Journal of Cardiovascular Computed Tomography|June 13, 2025
CT derived fractional flow reserve: Part 2 - Critical appraisal of the literaturePatricia F Rodriguez-Lozano, Anam Waheed, Sotirios Evangelou, et al.
Vaccines|September 27, 2025
Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of HypercholesterolemiaSuresh R Giri, Akshyaya Chandan Rath, Chitrang J Trivedi, et al.
BMJ Open|January 6, 2025
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trialSarah Al-Shakhshir, Mohammed Nabil Quraishi, Benjamin Mullish, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 16, 2023
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus StatementM Carbone, A Della Penna, C Mazzarelli, et al.
Cell Stem Cell|September 3, 2011
Lung stem cell self-renewal relies on BMI1-dependent control of expression at imprinted lociSima J Zacharek, Christine M Fillmore, Allison N Lau, et al.
Gastrointestinal Endoscopy|March 18, 2018
The Paddington International Virtual Chromoendoscopy Score in ulcerative colitis exhibits very good inter-rater agreement after computerized module training: a multicenter study across academic and community practice (with video)Palak J Trivedi, Ralf Kiesslich, James Hodson, et al.
Hepatology (Baltimore, Md.)|December 4, 2024
Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study designM Alan Brookhart, Tracy J Mayne, Charles Coombs, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary CholangitisNadir Abbas, Emma L Culver, Douglas Thorburn, et al.
Scientific Reports|April 29, 2016
Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureusStephen C Becker, Dwayne R Roach, Vinita S Chauhan, et al.
Pageof 35